DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Sante Ventures
Sante Ventures
Privately Held Companies
venture manager, reported GAV $977M across 7 vehicles
Importance
49
elevated
Active deployment
23
moderate
Emerging
0
low
Completeness
88
high
Freshness
100
high
Research priority
9
low
Identity and regulatory footprint
- Headquarters
- Austin, TXadviserinfo.sec.gov
- Office address
- 1300 RED RIVER STREET, SUITE 1500, Austin, TX, 78701adviserinfo.sec.gov
- Business phone
- 512-721-1200adviserinfo.sec.gov
- Website
- https://sante.com/
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 30, 2026
- Private funds reported
- 9 (9 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $1.3Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- French Investments I, LLC (Member), C
- business phone
- 512-721-1200adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
6 observed deals
Stated (the firm’s website)
- Sectors
- ai, healthcare, biotech, medtech
- Stages
- series a
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series a 50%seed 17%series c 17%series d plus 17%
Stage at first entry
series a 50%seed 17%series c 17%series d plus 17%
Sectors
unknown 100%
lead rate 50%follow-on rate 0%new logos, 12 months 6
Funds and vehicles
7 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Santé Health Ventures IV, LP | Fund | 2022 adv first reported | Active deployment | $220M Mar 27, 2024 | 26 | $0 of $250M | Mar 31, 2021 |
| Santé Health Ventures IV Parallel a, LP | Feeder or parallel | 2022 adv first reported | Active deployment | $90.7M Mar 27, 2024 | 1 | unknown | unknown |
| Santé Health Ventures III Parallel a, L.P. | Feeder or parallel | 2020 adv first reported | Mature | $151M Mar 27, 2024 | 1 | unknown | unknown |
| Sante Health Ventures III, LP | Fund | 2019 adv first reported | Mature | $348M Mar 27, 2024 | 31 | $0 of $200M | Feb 27, 2018 |
| Sante Health Ventures I Annex Fund, LP | Continuation vehicle | 2016 adv first reported | Harvest | $4.1M Mar 27, 2024 | 1 | $0 of $15.0M | Apr 30, 2015 |
| Sante Health Ventures Fund II, LP | Fund | 2011 form d first sale | Harvest | $84.7M Mar 27, 2024 | 21 | $139M of $139M | Apr 11, 2014 |
| Sante Health Ventures Fund I, LP | Fund | unknown | Unknown | $77.6M Mar 27, 2024 | 25 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
31 current, 5 departed
Kyle Schroeder
AnalystSenior Analyst
Decision Makers
AssociateInvestment Team
Ryan Hall
AssociateAssociate
Michael Hoffman
Board or advisorySenior Advisor
Brooke Jones
Investor relationsHead of Capital Formation
Doug Dewitt French
Managing partnerManaging Member · since Sep 1, 2013
Casey Cunningham
PartnerPartner
Dennis McWilliams
PartnerManaging Director
Douglas French
PartnerFounding Managing Director
James Eadie
PartnerManaging Director
Joe Cunningham
PartnerFounding Managing Director
JOE Hal Cunningham
PartnerManaging Director · since Jun 1, 2007
Kevin Lalande
PartnerFounding Managing Director
Kevin Lalande
PartnerFounding Managing Director and Chief Investment Officer
Kevin Myles Lalande
PartnerManaging Director · since Jun 1, 2007
Omar Khalil
PartnerManaging Director
Paula J. French
PartnerMember · since Sep 1, 2013
Chas Juliano
Platform and operationsCONTROLLER
Diane Brouillard
Platform and operationsHead of Talent & Networks
Jake Rogers
Platform and operationsHead of Operations
Jason Charles Brandt
Platform and operationsChief Financial Officer And Chief Compliance Officer · since Jan 1, 2019
Jeff Crawford
Platform and operationsHead of Finance
Laura McMillian
Platform and operationsOffice Manager
Auriel August
PrincipalPrincipal
Michael Gutbrod
PrincipalPrincipal
Ashley Seehusen
Venture partnerVenture Partner
Louis Bock
Venture partnerVenture Partner
Thomas Krummel
Venture partnerVenture Partner
William Cohn
Venture partnerVenture Partner
Alana Horowitz
Vice presidentSenior Associate
Mateo Vargas
Vice presidentSenior Associate
5 departed (kept with end dates)
- Steven Earl Seach · Operating Partner And Chief Operating Officer · Sep 1, 2012 to Dec 2, 2014 Inference
- Alfred Morse Macdaniel · General Counsel · Oct 1, 2014 to Mar 26, 2015 Inference
- David Ebert Kaufman · Chief Operating Officer · Jan 1, 2019 to Mar 30, 2023 Inference
- Stephen Irvin Sanders · Vp Finance & Accounting, Cco · May 1, 2016 to Mar 14, 2019 Inference
- William Robert Paape · Chief Financial Officer · Oct 1, 2014 to Aug 29, 2016 Inference
Investments on record
6 edges, 6 companies, 1 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
10 relationships from shared deals, counted for the whole firm
Fast Track Initiative 1 shared · one time · we led 1Gilde Healthcare 1 shared · one time · they led 1Panakès Partners 1 shared · one timeNorwest 1 shared · one time · they led 1L Healthcare Investments 1 shared · one timeS3 Ventures 1 shared · one timeEight Roads GP 1 shared · one timeEight Roads Ventures 1 shared · one timeEarlybird Venture Capital 1 shared · one timeKOFA Healthcare 1 shared · one time
Limited partners
2 disclosed
Timeline
19 dated events
- Mar 30, 2023David Ebert Kaufman (Chief Operating Officer) no longer on Schedule A of Sante Ventures
- Mar 31, 2022Santé Health Ventures IV Parallel a, LP first reported on Form ADV by Sante Ventures (Venture Capital Fund), GAV $76,973,570Fund first reported on Form ADVFundsFactSanté Health Ventures IV Parallel a, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2022Santé Health Ventures IV, LP first reported on Form ADV by Sante Ventures (Venture Capital Fund), GAV $185,993,880Fund first reported on Form ADVFundsFactSanté Health Ventures IV, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 23, 2020Santé Health Ventures III Parallel a, L.P. first reported on Form ADV by Sante Ventures (Venture Capital Fund), GAV $164,865,836Fund first reported on Form ADVFundsFactSanté Health Ventures III Parallel a, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 14, 2019Stephen Irvin Sanders (Vp Finance & Accounting, Cco) no longer on Schedule A of Sante Ventures
- Mar 14, 2019Sante Health Ventures III, LP first reported on Form ADV by Sante Ventures (Venture Capital Fund), GAV $9,005,332Fund first reported on Form ADVFundsFactSante Health Ventures III, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 1, 2019Jason Charles Brandt joined Schedule A of Sante Ventures as Chief Financial Officer And Chief Compliance Officer
- Jan 1, 2019David Ebert Kaufman joined Schedule A of Sante Ventures as Chief Operating Officer
- Aug 29, 2016William Robert Paape (Chief Financial Officer) no longer on Schedule A of Sante Ventures
- May 1, 2016Stephen Irvin Sanders joined Schedule A of Sante Ventures as Vp Finance & Accounting, Cco
- Mar 2, 2016Sante Health Ventures I Annex Fund, LP first reported on Form ADV by Sante Ventures (Venture Capital Fund), GAV $9,905,396Fund first reported on Form ADVFundsFactSante Health Ventures I Annex Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 26, 2015Alfred Morse Macdaniel (General Counsel) no longer on Schedule A of Sante Ventures
- Dec 2, 2014Steven Earl Seach (Operating Partner And Chief Operating Officer) no longer on Schedule A of Sante Ventures
- Oct 1, 2014William Robert Paape joined Schedule A of Sante Ventures as Chief Financial Officer
- Sep 1, 2013Paula J. French joined Schedule A of Sante Ventures as Member
- Sep 1, 2012Steven Earl Seach joined Schedule A of Sante Ventures as Operating Partner And Chief Operating Officer
- Mar 30, 2012Sante Health Ventures Fund I, LP first reported on Form ADV by Sante Ventures (Venture Capital Fund), GAV $129,714,264Fund first reported on Form ADVFundsFactSante Health Ventures Fund I, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Sante Health Ventures Fund II, LP first reported on Form ADV by Sante Ventures (Venture Capital Fund), GAV $126,613,915Fund first reported on Form ADVFundsFactSante Health Ventures Fund II, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Sante Ventures first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $977M across 7 vehicles
Evidence
59 observations from 4 sources